Article
Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.
The Pediatric infectious disease journal - 1 Jan 2008
Hatchette Todd, Tipples Graham A, Peters Geoff, Alsuwaidi Ahmed, Zhou Jianwei, Mailman Timothy Lloyd
Abstract excerpt
The authors describe an acyclovir-resistant varicella zoster virus infection in a pediatric patient after hematopoietic stem cell transplant, the use of foscarnet as salvage therapy, and review the literature to clarify the pediatric experience with foscarnet in this setting. A novel thymidine kinase mutation is described, along with a new phenotypic assay for characterizing acyclovir resistance in varicella...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
